Related Experiment Video
Updated: Jun 28, 2026
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Novel vaccines: bridging research, development and production
1Department of Medicine, Division of Infectious Diseases, Children's Hospital, Boston, MA 02115, USA.
Expert Review of Vaccines
|November 5, 2008
Summary
Vaccine development continues to advance, addressing limitations of conventional vaccines and unmet needs for diseases like HIV and malaria. Experts convened to discuss novel vaccine development and production challenges.
Area of Science:
- Immunology and Infectious Diseases
- Medical Research and Development
Background:
- Vaccines have historically eradicated diseases like smallpox and controlled others, but limitations persist.
- Current vaccines offer incomplete protection and fail to address critical infectious diseases such as HIV, hepatitis C, and malaria.
Framework:
- The 3rd Annual Immunotherapeutics and Vaccine Summit (ImVacS 2008) convened global experts.
- Discussions focused on the latest advancements and challenges in vaccine development and production.
Implementation:
- 64 presentations highlighted cutting-edge research and strategies.
- The summit facilitated dialogue on overcoming hurdles in creating new and improved vaccines.
Implications:
- Addresses the urgent need for novel vaccines against persistent and emerging infectious diseases.
- Highlights the ongoing global effort to enhance vaccine efficacy and expand coverage.
- Emphasizes the critical role of scientific collaboration in tackling global health challenges.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...